HBW Insight

Shortlist Announced for the 2021 OTC Marketing Awards

21 Oct 2021

London – 21 October 2021 – Finalists vying for the top awards in the British OTC industry were announced today, as Informa Pharma Intelligence revealed its shortlist for the 26th Annual OTC Marketing Awards. Winners will be named during a lavish ceremony on 1 December 2021 at the Royal Lancaster London hotel, during which the outstanding achievements of those working across a full range of OTC activities in Great Britain will be honoured.

Topic OTC Drugs

HBW Insight

Lessons Learned: European Self-Care Industry Will Come Out Of Pandemic Stronger

By David Ridley 08 Dec 2020

Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.

Topic EU OTC Drugs Coronavirus

HBW Insight

UK Researchers Seek Commercial Partner For Nasal Spray Shown To 'Prevent' COVID-19

By Tom Gallen 29 Nov 2020

A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.

Topic Coronavirus Research & Development Vaccines OTC Drugs

HBW Insight

Merz Consumer Care Optimistic About Future As German Lockdown Continues

By David Ridley 29 Nov 2020

Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure. 

Topic Coronavirus OTC Drugs EU

HBW Insight

Bayer Harnessing Skin Microbiome In New Product Development

By Tom Gallen 27 Nov 2020

Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

Topic Business Strategies Innovation OTC Drugs

HBW Insight

OTC Drug Oversight By US FDA Split Among Two Divisions In Reorganization

By Malcolm Spicer 27 Jan 2020

CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.

Topic Drug Review FDA OTC Drugs

HBW Insight

OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

15 Jan 2020

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

Topic Dietary Supplements OTC Drugs Recalls

HBW Insight

Steripod Bolt-on Deal Extends Perrigo Into Toothbrush And Razor Accessories

By Eileen Francis 08 Jan 2020

Perrigo's Ranir division purchased the brand, which includes a portfolio of antibacterial toothbrush protectors, children’s products and tongue cleaners, for an undisclosed amount from Bonfit America.

Topic M A OTC Drugs

HBW Insight

Reckitt Targets UK's Painful 'Tweens' With Double-Strength Nurofen

By David Ridley 18 Dec 2019

Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."

Topic Launches OTC Drugs